Related items
Trial Projects:
- Anti-Stress Intervention Among Physicians (ASIP)
- Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy (FREE-AI)
- Combined N-of-1 Trials to Assess Open-Label Placebo Treatment for Antidepressant Discontinuation Symptoms [FAB-study]
- N-of-1 trials to improve sleep 2024
- N-of-1 trials to improve sleep 2023
- Trying out treatments for chronic pain through personalised behavioural studies (Pilot study)
Institutions: Hasso Plattner Institute (HPI)

Trial Projects:
- Anti-Stress Intervention Among Physicians (ASIP)
- Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy (FREE-AI)
- Combined N-of-1 Trials to Assess Open-Label Placebo Treatment for Antidepressant Discontinuation Symptoms [FAB-study]
- N-of-1 trials to improve sleep 2024
- N-of-1 trials to improve sleep 2023
- Trying out treatments for chronic pain through personalised behavioural studies (Pilot study)
Institutions: Hasso Plattner Institute (HPI)
It has been widely recognized that the placebo effect has a profound impact on treatment outcome in many different conditions. Recent studies imply that this effect appears even if placebos are openly administered; so called "open-label placebos" (OLP). Compelling evidence suggests the efficacy of OLP in the treatment of pain disorders, neuropsychological syndromes, menopausal hot flushes, depression and allergic rhinitis. Research on the underlying mechanisms of OLP is scarce, yet studies indicate ...
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Public web page: http://phea-studie.de/fab
Start date: 17th Feb 2022
End date: 15th May 2024
Abstract (Expand)
Authors: Amke Müller, Stefan Konigorski, Carina Meißner, Tahmine Fadai, Claire V. Warren, Irina Falkenberg, Tilo Kircher, Yvonne Nestoriuc
Date Published: 1st Dec 2023
Publication Type: Journal
DOI: 10.1186/s12888-023-05184-y
Citation: BMC Psychiatry 23(1),749